chr2-130190508-C-G

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_025029.5(MZT2B):​c.359C>G​(p.Ala120Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)

Consequence

MZT2B
NM_025029.5 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.170
Variant links:
Genes affected
MZT2B (HGNC:25886): (mitotic spindle organizing protein 2B) Located in cytosol; microtubule cytoskeleton; and nucleoplasm. Part of gamma-tubulin large complex. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.07488966).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MZT2BNM_025029.5 linkc.359C>G p.Ala120Gly missense_variant Exon 3 of 3 ENST00000281871.11 NP_079305.2 Q6NZ67

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MZT2BENST00000281871.11 linkc.359C>G p.Ala120Gly missense_variant Exon 3 of 3 1 NM_025029.5 ENSP00000281871.7 Q6NZ67

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Nov 25, 2024
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.359C>G (p.A120G) alteration is located in exon 3 (coding exon 3) of the MZT2B gene. This alteration results from a C to G substitution at nucleotide position 359, causing the alanine (A) at amino acid position 120 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.068
BayesDel_addAF
Benign
-0.18
T
BayesDel_noAF
Benign
-0.50
CADD
Benign
4.3
DANN
Benign
0.88
DEOGEN2
Benign
0.022
.;T;.
Eigen
Benign
-0.90
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.058
N
LIST_S2
Benign
0.63
T;T;T
M_CAP
Benign
0.0042
T
MetaRNN
Benign
0.075
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.71
.;N;.
PrimateAI
Uncertain
0.67
T
PROVEAN
Benign
-1.1
N;N;N
REVEL
Benign
0.026
Sift
Benign
0.18
T;T;T
Sift4G
Benign
0.37
T;T;T
Polyphen
0.42
.;B;.
Vest4
0.090, 0.10
MutPred
0.26
.;Loss of helix (P = 0.0041);.;
MVP
0.068
MPC
0.11
ClinPred
0.16
T
GERP RS
0.19
RBP_binding_hub_radar
0.92
RBP_regulation_power_radar
2.0
Varity_R
0.044
gMVP
0.099

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr2-130948081; API